Enzymology of Mismatch Repair in Yeast
Enzymology of Mismatch Repair in Yeast
批准号:
7883713
负责人:
Richard D Kolodner
金额:
$5.35万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-20 至 2009-11-30
关键词:
AddressAllelesBiochemicalBiochemical GeneticsBiological ModelsCell Cycle ArrestCell DeathCharacteristicsChemicalsCollaborationsComplexCoupledDNADNA DamageDNA SequenceDNA biosynthesisDefectDissectionEnzymatic BiochemistryEukaryotic CellEventExcisionGene MutationGene ProteinsGenesGeneticGenetic RecombinationGenetic ScreeningGenomic InstabilityGoalsHealthHereditary Nonpolyposis Colorectal NeoplasmsHomologous GeneHumanHuman GeneticsIn VitroIndividualInheritedLeadMalignant NeoplasmsMediatingMismatch RepairModelingMolecular ModelsMusMutationPathway interactionsPlayPredispositionPropertyProteinsProteomicsReactionResistanceRoleSaccharomyces cerevisiaeSignal TransductionSystemYeastsbasechemotherapyin vivoinsightinterestkillingsmolecular modelingmouse modelmutantnucleasepreventprotein complexprotein functionreconstitutionrepairedresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DNA mismatch repair (MMR) plays a number of critical roles in eukaryotic cells including: 1) suppression
of mutations that result from misincorportation errors during DNA replication as well as chemical damage to
DNA and DNA precursors; 2) repair of mispaired bases in recombination intermediates; 3) preventing
recombination between divergent DNA sequences; and 4) signaling the presence of DNA damage resulting
in cellular responses such as cell cycle arrest and cell death. As a consequence of these cellular roles,
MMR defects increase the spontaneous mutation rate and the rate of altered recombination events resulting
in a characteristic genome instability signature as well as resulting in increased resistance to killing by some
DNA damaging agents. Understanding the mechanism of MMR will impact human health for a number of
reasons: 1) Hereditary non-polyposis colon cancer is due to inherited defects in MMR and many sporadic
cancers appear MMR defective, yet the genetic consequences of MMR defects are not fully understood; and,
2) many chemotherapy agents damage DNA and MMR defects can result in resistance to some of these
agents so understanding MMR could lead to improvements in the efficacy of these agents as well as ways to
circumvent MMR defect-mediated resistance.
The goal of this proposal is to use Saccharomyces cerevisiae to study the biochemical and genetic
mechanisms of the eukaryotic MutS- and MutL-horriologue dependent MMR pathways. The following lines
of experimentation will be carried out: 1) genetic studies will identify MMR genes and mutations for use in
dissecting the biochemical properties of MMR proteins; 2) biochemical studies of individual MMR proteins
including the Msh2-Msh3, Msh2-Msh6, Mlh1-Pms1 and Mlh1-Mlh3 complexes, RPA, PCNA, RFC, Exo1, and
other proteins will be continued to determine the roles these proteins play in MMR; 3) the biochemical basis
for the higher order protein complexes that function in MMR will be determined; 4) partial and complete MMR
reactions will be reconstituted in vitro using purified proteins to study the mechanisms of MMR; and 5)
collaborative mouse model studies will be continued to extend insights from studies with S. cerevisiae to
mammalian systems. The ultimate goal of these experiments is to reconstitute MMR with purified proteins
and determine the mechanisms of these reactions. A key feature of these studies is the use of S. cerevisiae
to explore questions raised by the genetics of human cancer susceptibility, and collaborative mouse studies
to explore the broader implications of results developed in S. cerevisiae. As a consequence, it is anticipated
that these studies will provide genetic and biochemical insights that can be applied to the study of the
genetics of human cancer susceptibility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
-
批准号:10467002
-
项目类别:
-
资助金额:$62.67万
-
财政年份:2021
-
负责人:Richard D Kolodner
-
依托单位:
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
-
批准号:10675534
-
项目类别:
-
资助金额:$62.67万
-
财政年份:2021
-
负责人:Richard D Kolodner
-
依托单位:
CANCER GENETICS
-
批准号:6599269
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:Richard D Kolodner
-
依托单位:
CANCER GENETICS
-
批准号:6592152
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:Richard D Kolodner
-
依托单位:
CANCER GENETICS
-
批准号:6653295
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6655791
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6657048
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:Richard D Kolodner
-
依托单位:
CANCER GENETICS
-
批准号:6501412
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2001
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6496671
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2001
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6354609
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY FACILITY
-
批准号:6345917
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2000
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY FACILITY
-
批准号:6201101
-
项目类别:
-
资助金额:$18.8万
-
财政年份:1999
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6101363
-
项目类别:
-
资助金额:$30.51万
-
财政年份:1999
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6299901
-
项目类别:
-
资助金额:$30.51万
-
财政年份:1999
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6099443
-
项目类别:
-
资助金额:$11.77万
-
财政年份:1998
-
负责人:Richard D Kolodner
-
依托单位:
MODEL SYSTEMS FOR ANALYSIS OF GENETIC SUSCEPTIBILITY TO COLON CANCER
-
批准号:6102368
-
项目类别:
-
资助金额:$14.15万
-
财政年份:1998
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY COMPONENT
-
批准号:6102370
-
项目类别:
-
资助金额:$14.15万
-
财政年份:1998
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6268519
-
项目类别:
-
资助金额:$31.96万
-
财政年份:1998
-
负责人:Richard D Kolodner
-
依托单位:
MODEL SYSTEMS FOR ANALYSIS OF GENETIC SUSCEPTIBILITY TO COLON CANCER
-
批准号:6236889
-
项目类别:
-
资助金额:$18.43万
-
财政年份:1997
-
负责人:Richard D Kolodner
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6235915
-
项目类别:
-
资助金额:$28.57万
-
财政年份:1997
-
负责人:Richard D Kolodner
-
依托单位:
海外基金